Abbott Laboratories (ABT) is a Healthcare · Medical Devices company listed on NYSE. Price $102.61 (+0.37%), Market cap $152.88B, P/E ratio 24.59, 52-week low–high $82.56 ~ $138.08.
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromy
Financial statements, price targets, institutional (13F) holdings and related news for Abbott Laboratories are updated in real time on BlackAll Trade.
6 recent posts · 6 bullish · 0 bearish · 0 neutral.
Abbott Laboratories trades at $102.61 (+0.37%). Real-time quotes and charts are available on BlackAll Trade.
Abbott Laboratories has a market cap of about $152.88B. Its P/E ratio is 24.59.
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Dia